Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Cefotaxime breakpoint for Streptococcus pneumoniae.

Literature DB >> 8460930

Cefotaxime breakpoint for Streptococcus pneumoniae.

E Cantón.

Abstract

Entities: Chemical

Mesh：

Substances：
Cefotaxime

Year: 1993 PMID： 8460930 PMCID： PMC187718 DOI： 10.1128/AAC.37.3.616

Source DB: PubMed Journal: Antimicrob Agents Chemother ISSN： 0066-4804 Impact factor: 5.191

× No keyword cloud information.

12 in total

1. A pneumococcal clinical isolate with high-level resistance to cefotaxime and ceftriaxone.

Authors: A M Figueiredo; J D Connor; A Severin; M V Vaz Pato; A Tomasz
Journal: Antimicrob Agents Chemother Date: 1992-04 Impact factor: 5.191

2. Multicenter evaluation of the use of Haemophilus test medium for broth microdilution antimicrobial susceptibility testing of Streptococcus pneumoniae and development of quality control limits.

Authors: J H Jorgensen; G V Doern; M J Ferraro; C C Knapp; J M Swenson; J A Washington
Journal: J Clin Microbiol Date: 1992-04 Impact factor: 5.948

3. Ceftriaxone failure in meningitis caused by Streptococcus pneumoniae with reduced susceptibility to beta-lactam antibiotics.

Authors: J S Bradley; J D Connor
Journal: Pediatr Infect Dis J Date: 1991-11 Impact factor: 2.129

4. Antibiotic concentrations in liquor compared to the minimal inhibitory concentrations of isolates in paediatric bacterial meningitis. The Finnish Study Group.

Authors: J K Ellmén; O V Renkonen; M A Anttila; H O Peltola
Journal: Chemotherapy Date: 1991 Impact factor: 2.544

5. Imipenem/cilastatin treatment of bacterial meningitis in children.

Authors: V K Wong; H T Wright; L A Ross; W H Mason; C B Inderlied; K S Kim
Journal: Pediatr Infect Dis J Date: 1991-02 Impact factor: 2.129

6. Pneumococcal meningitis in a child with a ventriculo-peritoneal shunt.

Authors: P T O'Keeffe; R Bayston
Journal: J Infect Date: 1991-01 Impact factor: 6.072

Review 7. Bacterial meningitis: recent advances in pathophysiology and treatment.

Authors: A R Tunkel; B Wispelwey; W M Scheld
Journal: Ann Intern Med Date: 1990-04-15 Impact factor: 25.391

8. Cefotaxime in the cerebrospinal fluid and serum in patients with purulent meningitis.

Authors: P Peretti; L Sueri; M Tosi; R Ciammarughi; G P Cadeo; B Milanesi
Journal: J Antimicrob Chemother Date: 1984-09 Impact factor: 5.790

9. Systemic infections due to Streptococcus pneumoniae relatively resistant to penicillin in a children's hospital: clinical management and outcome.

Authors: T Q Tan; E O Mason; S L Kaplan
Journal: Pediatrics Date: 1992-12 Impact factor: 7.124

10. Evaluation of vancomycin for therapy of adult pneumococcal meningitis.

Authors: P F Viladrich; F Gudiol; J Liñares; R Pallarés; I Sabaté; G Rufí; J Ariza
Journal: Antimicrob Agents Chemother Date: 1991-12 Impact factor: 5.191

11 in total

1. Killing activities of trovafloxacin alone and in combination with beta-lactam agents, rifampin, or vancomycin against Streptococcus pneumoniae isolates with various susceptibilities to extended-spectrum cephalosporins at concentrations clinically achievable in cerebrospinal fluid.

Authors: F Fitoussi; C Doit; P Geslin; E Bingen
Journal: Antimicrob Agents Chemother Date: 1999-10 Impact factor: 5.191

2. Comparative in vitro killing activities of meropenem, imipenem, ceftriaxone, and ceftriaxone plus vancomycin at clinically achievable cerebrospinal fluid concentrations against penicillin-resistant Streptococcus pneumoniae isolates from children with meningitis.

Authors: F Fitoussi; C Doit; K Benali; S Bonacorsi; P Geslin; E Bingen
Journal: Antimicrob Agents Chemother Date: 1998-04 Impact factor: 5.191

3. More about cefuroxime screening test for pneumococci.

Authors: H A Lopardo; L Lovadina; E A Rubeglio
Journal: J Clin Microbiol Date: 1995-04 Impact factor: 5.948

4. Detection of Salmonella species in fecal samples by immunomagnetic separation and PCR.

Authors: A C Fluit; M N Widjojoatmodjo; J Verhoef
Journal: J Clin Microbiol Date: 1995-04 Impact factor: 5.948

5. Killing activity of cefpirome against penicillin-resistant Streptococcus pneumoniae isolates from patients with meningitis in a pharmacodynamic model simulating the cerebrospinal fluid concentration profile.

Authors: F Fitoussi; C Doit; A Sandin; A Pechinot; A Kazmierczack; P Geslin; E Bingen
Journal: Antimicrob Agents Chemother Date: 1995-11 Impact factor: 5.191

6. Development of interpretive criteria and quality control limits for broth microdilution and disk diffusion antimicrobial susceptibility testing of Streptococcus pneumoniae.

Authors: J H Jorgensen; J M Swenson; F C Tenover; M J Ferraro; J A Hindler; P R Murray
Journal: J Clin Microbiol Date: 1994-10 Impact factor: 5.948

7. In vitro killing activities of antibiotics at clinically achievable concentrations in cerebrospinal fluid against penicillin-resistant Streptococcus pneumoniae isolated from children with meningitis.

Authors: C P Doit; S P Bonacorsi; A J Fremaux; G Sissia; R Cohen; P L Geslin; E H Bingen
Journal: Antimicrob Agents Chemother Date: 1994-11 Impact factor: 5.191

8. High doses of cefotaxime in treatment of adult meningitis due to Streptococcus pneumoniae with decreased susceptibilities to broad-spectrum cephalosporins.

Authors: P F Viladrich; C Cabellos; R Pallares; F Tubau; J Martínez-Lacasa; J Liñares; F Gudiol
Journal: Antimicrob Agents Chemother Date: 1996-01 Impact factor: 5.191

9. Moxifloxacin in the therapy of experimental pneumococcal meningitis.

Authors: H Schmidt; A Dalhoff; K Stuertz; F Trostdorf; V Chen; O Schneider; C Kohlsdorfer; W Brück; R Nau
Journal: Antimicrob Agents Chemother Date: 1998-06 Impact factor: 5.191

10. High rate of erythromycin and clarithromycin resistance among Streptococcus pneumoniae isolates from blood cultures from Providence, R.I.

Authors: J R Lonks; A A Medeiros
Journal: Antimicrob Agents Chemother Date: 1993-09 Impact factor: 5.191